# Clinical Trial of Efficacy and Safety of Subetta in the Treatment of Impaired Glucose Tolerance

> **NCT03725033** · PHASE3 · COMPLETED · sponsor: **Materia Medica Holding** · enrollment: 538 (actual)

## Conditions studied

- Impaired Glucose Tolerance

## Interventions

- **DRUG:** Subetta
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03725033
- **Lead sponsor:** Materia Medica Holding
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-10
- **Primary completion:** 2020-03-23
- **Final completion:** 2020-03-23
- **Target enrollment:** 538 (ACTUAL)
- **Last updated:** 2021-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03725033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03725033, "Clinical Trial of Efficacy and Safety of Subetta in the Treatment of Impaired Glucose Tolerance". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03725033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*